Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 · Science Translational Medicine · 693 citations
https://doi.org/10.1126/scitranslmed.3008095
D
Dmitriy Zamarin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
377
Papers
15.2K
Citations
57
h-index
124
i10-index
Dmitriy Zamarin is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments. The author has an h-index of 57, co-authored 321 publications.
ORCID: 0000-0002-0094-0161Papers by this author
worksBlockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
2020 · Nature Communications · 418 citations
https://doi.org/10.1038/s41467-020-17750-z
Ovarian cancer mutational processes drive site-specific immune evasion
2022 · Nature · 272 citations
https://doi.org/10.1038/s41586-022-05496-1
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
2018 · Journal of Clinical Investigation · 147 citations
https://doi.org/10.1172/jci98047
Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
2016 · EBioMedicine · 144 citations
https://doi.org/10.1016/j.ebiom.2016.02.024
Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers
2020 · Scientific Reports · 68 citations
https://doi.org/10.1038/s41598-020-72475-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat